A bill to hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.
About This Bill
Committee
Latest Action · May 21, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.